Metastatic insulinoma

Common Name(s)

Metastatic insulinoma

Metastatic insulinoma is a rare form of pancreatic cancer that also causes high levels of insulin in a person’s body. The pancreas is the organ that makes insulin, and insulin is a messenger that tells the body to break down sugars to make energy needed for daily life. Symptoms of metastatic insulinoma include lethargy and blurred vision when after long periods of not eating or exercise. Treatment usually includes surgery, however, if you have been diagnosed with metastatic insulinoma, you should talk with your doctor about the best treatment for you.

Source: Advocacy organizations associated with the condition.

 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic insulinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Metastatic insulinoma" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Metastatic insulinoma" returned 8 free, full-text research articles on human participants. First 3 results:

Detection of metastatic insulinoma by positron emission tomography with [(68)ga]exendin-4-a case report.
 

Author(s): Olof Eriksson, Irina Velikyan, Ram K Selvaraju, Fouad Kandeel, Lars Johansson, Gunnar Antoni, Barbro Eriksson, Jens Sörensen, Olle Korsgren

Journal: J. Clin. Endocrinol. Metab.. 2014 May;99(5):1519-24.

 

Insulinomas are the most common cause of endogenous hyperinsulinemic hypoglycemia in nondiabetic adult patients. They are usually benign, and curative surgery is the "gold standard" treatment if they can be localized. Malignant insulinomas are seen in less than 10% of patients, and ...

Last Updated: 7 May 2014

Go To URL
Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.
 

Author(s): Valérie Bernard, Catherine Lombard-Bohas, Marie-Caroline Taquet, François-Xavier Caroli-Bosc, Philippe Ruszniewski, Patricia Niccoli, Rosine Guimbaud, Cécile N Chougnet, Bernard Goichot, Vincent Rohmer, Françoise Borson-Chazot, Eric Baudin,

Journal:

 

Refractory hypoglycemia in patients with metastatic insulinoma is an important cause of morbidity and mortality. Everolimus could be a new therapeutic option.

Last Updated: 16 Apr 2013

Go To URL
Metastatic insulinoma - prolonged survival after multimodal approach.
 

Author(s): Alexander F Hagel, Wolfgang H Hagel, Annette S Lindner, Ferdinand J Kammerer, Markus F Neurath, Peter C Konturek, Igor A Harsch

Journal: Med. Sci. Monit.. 2011 Aug;17(8):CS103-107.

 

Metastatic insulinoma is a disease associated with a poor life expectancy.

Last Updated: 1 Aug 2011

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Metastatic insulinoma" returned 0 free, full-text review articles on human participants.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
 

Status: Recruiting

Condition Summary: Gastrinoma; Glucagonoma; Insulinoma; Metastatic Gastrointestinal Carcinoid Tumor; Pancreatic Polypeptide Tumor; Pulmonary Carcinoid Tumor; Recurrent Gastrointestinal Carcinoid Tumor; Recurrent Islet Cell Carcinoma; Somatostatinoma

 

Last Updated: 18 Apr 2017

Go to URL
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
 

Status: Not yet recruiting

Condition Summary: Functional Pancreatic Neuroendocrine Tumor; Malignant Somatostatinoma; Merkel Cell Carcinoma; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Carcinoid Tumor; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2A; Multiple Endocrine Neoplasia Type 2B; Neuroendocrine Neoplasm; Non-Functional Pancreatic Neuroendocrine Tumor; Pancreatic Glucagonoma; Pancreatic Insulinoma; Recurrent Adrenal Cortex Carcinoma; Recurrent Adrenal Gland Pheochromocytoma; Recurrent Merkel Cell Carcinoma; Somatostatin-Producing Neuroendocrine Tumor; Stage III Adrenal Cortex Carcinoma; Stage III Thyroid Gland Medullary Carcinoma; Stage IIIA Merkel Cell Carcinoma; Stage IIIB Merkel Cell Carcinoma; Stage IV Adrenal Cortex Carcinoma; Stage IV Merkel Cell Carcinoma; Stage IVA Thyroid Gland Medullary Carcinoma; Stage IVB Thyroid Gland Medullary Carcinoma; Stage IVC Thyroid Gland Medullary Carcinoma; Thymic Carcinoid Tumor; VIP-Producing Neuroendocrine Tumor; Well Differentiated Adrenal Cortex Carcinoma; Zollinger Ellison Syndrome

 

Last Updated: 14 Jul 2017

Go to URL